Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 5/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | ADH1B | P00325 | 1/20 | 0.38 |
| ▸ | ADH1C | P00326 | 1/20 | 0.38 |
| ▸ | ADH1A | P07327 | 1/20 | 0.38 |
| ▸ | ADH4 | P08319 | 1/20 | 0.38 |
| ▸ | ADH7 | P40394 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL480983 | 1.00 | DNM1 (0.44) | DNM1TSHRTHRBFAAHTRPV1 | |
| SCHEMBL19511994 | 1.00 | DNM1 (0.44) | DNM1TSHRTHRBFAAHTRPV1 | |
| SCHEMBL4259961 | 1.00 | DNM1 (0.44) | DNM1TSHRTHRBFAAHTRPV1 | |
| SCHEMBL10337322 | 1.00 | DNM1 (0.44) | DNM1TSHRTHRBFAAHTRPV1 | |
| SCHEMBL3458341 | 1.00 | DNM1 (0.44) | DNM1TSHRTHRBFAAHTRPV1 | |
| SCHEMBL7698918 | 0.98 | DNM1 (0.40) | DNM1TSHRTHRBFAAHTRPV1 | |
| SCHEMBL9014021 | 0.95 | TSHR (0.42) | DNM1TSHRTHRBFAAHTRPV1 | |
| SCHEMBL19511992 | 0.95 | TSHR (0.42) | DNM1TSHRTHRBFAAHTRPV1 | |
| SCHEMBL1900761 | 0.95 | TSHR (0.42) | DNM1TSHRTHRBFAAHTRPV1 | |
| SCHEMBL13279660 | 0.95 | TSHR (0.42) | DNM1TSHRTHRBFAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023062074-A1 | PROCESS FOR THE PREPARATION OF LOW-COLOR ALKYL POLYGLYCOSIDES, INVOLVING NEUTRALIZATION OF THE REACTION MEDIUM BEFORE REMOVAL OF THE SUGAR | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2023-04-20 | — | — | WO | claimed |
| WO-2023062078-A1 | PROCESS FOR THE PREPARATION OF LOW-COLOR ALKYL POLYGLYCOSIDES, INVOLVING NEUTRALIZATION OF THE REACTION MEDIUM AFTER REMOVAL OF THE SUGAR | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2023-04-20 | — | — | WO | claimed |
| WO-2023062077-A1 | PROCESS FOR THE PREPARATION OF LOW-COLOR ALKYL POLYGLYCOSIDES, INVOLVING PRE-NEUTRALIZATION OF THE REACTION MEDIUM | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2023-04-20 | — | — | WO | claimed |
| CN-105131258-A | Regionally-regular polymer containing asymmetric monofluoro-substituted 2,1,3-benzothiadiazole group and application of regionally-regular polymer | NANJING ORGANIC NANO ELECTRONIC INC | 2015-12-09 | — | — | CN | claimed |
| CN-101490072-B | Sugar derivatives, method for the production thereof, and use thereof as surfactants | SEPPIC SA | 2014-02-26 | — | — | CN | claimed |
| CN-103153265-A | Novel oil-in-water cosmetic emulsions including N-acylated derivatives having a high melting point, and methods for preparing same | SEPPIC SA | 2013-06-12 | — | — | CN | claimed |
| CN-102066395-A | Novel compositions based on ethers of alkyl polyosides and on alkyl glyceryl ethers, use thereof as an emulsifier and cosmetic compositions containing same | SEPPIC SA | 2011-05-18 | — | — | CN | claimed |
| CN-1839143-B | Ascorbic acid derivatives and skin-whitening cosmetics | TOYO BEAUTY CO LTD | 2011-04-06 | — | — | CN | claimed |
| CN-101490072-A | Novel sugar derivatives, method for the production thereof, and use thereof as surfactants | SEPPIC SA (FR) | 2009-07-22 | — | — | CN | claimed |
| CN-1839143-A | Ascorbic acid derivatives and skin-whitening cosmetics | TOYO BEAUTY CO LTD (JP) | 2006-09-27 | — | — | CN | claimed |
| US-20240228515-A1 | BORON-CONTAINING TRIPHENYLENE COMPOUNDS, COMPOSITIONS, AND ORGANIC ELECTRONIC DEVICES USING THE SAME | SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2024-07-11 | — | — | US | disclosed |
| US-12035616-B2 | Organic electroluminescence device and organometallic complex for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-09 | — | — | US | disclosed |
| US-20240224780-A1 | Organic Compound, Light-Emitting Element, and Display Panel | SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2024-07-04 | — | — | US | disclosed |
| EP-4358932-A1 | THICKENING COMPOSITION FOR THICKENING POLAR OR NON-POLAR OILS | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2024-05-01 | — | — | EP | disclosed |
| EP-4358933-A1 | COPOLYMER THICKENING COMPOSITION COMPRISING AT LEAST ONE OIL AND AT LEAST ONE POLY(ITACONATE) FOR THICKENING POLAR OR APOLAR OILS | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2024-05-01 | — | — | EP | disclosed |
| EP-1159251-A1 | ANTIOXIDANT COMPOSITIONS | Condea Vista Company (US) | 2001-12-05 | — | — | EP | disclosed |
| WO-2000051965-A9 | ANTIOXIDANT COMPOSITIONS | CONDEA VISTA CO (US) | 2001-11-22 | — | — | WO | disclosed |
| US-6303052-B1 | BETA-BRANCHED GUERBET ALCOHOL ESTESR OF HINDERED HYDROXYPHENYLALKANOIC ACIDS; LIQUID AT LOW TEMPERATURE, EXHIBIT HIGH PURITY, AND POSSESS A LOW FREEZING (POUR) POINT AND LOW VISCOSITY AT LOW TEMPERATURES | CONDEA VISTA COMPANY | 2001-10-16 | — | — | US | disclosed |
| WO-2000051965-A1 | ANTIOXIDANT COMPOSITIONS | CONDEA VISTA COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |
| CN-1090167-A | Skin-cleaning composition | UNILEVER NV (NL) | 1994-08-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12035616-B2 | Organic electroluminescence device and organometallic complex for organic electroluminescence device | L1CAM, EML4, EPCAM | DNM1 1220/4885TSHR 3950/4885THRB 4718/4885 |
| US-20240228515-A1 | BORON-CONTAINING TRIPHENYLENE COMPOUNDS, COMPOSITIONS, AND ORGANIC ELECTRONIC DEVICES USING THE SAME | NR0B2, NR0B1, NR2E1 | DNM1 3967/4885TSHR 389/4885THRB 233/4885 |
| US-20240224780-A1 | Organic Compound, Light-Emitting Element, and Display Panel | NR2E3, NR0B2, C5 | DNM1 4592/4885TSHR 2903/4885THRB 1529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.